30% off. Use code SUMMERSALE30 at checkout for 30% off for 12 months on Plus, Pro and Premium subscriptions. Subscribe now

Dan Passeri

Insider profile

Currently holds a position at Cue Biopharma Inc

Performance

Overall performance
2.5

Performance over holding periods
2.5
30 days 90 days 120 days
Average return 1% 8.2% 15.1%
Success rate 43% 68% 82%
Transactions
5 100% Buy
34 71% Buy
47 69% Buy

Positions

Position Company Period
Chief Executive Officer, Director Cue Biopharma Inc Oct. 3, 2019 -
President, Chief Executive Officer, Director Cue Biopharma Inc Jan. 1, 2017 - Oct. 3, 2019
President, Chief Executive Officer Cue Biopharma Inc Jan. 1, 2016 - Jan. 1, 2017
Vice Chairman of the Board Curis Inc June 2, 2014 - Sept. 14, 2016
Chief Executive Officer, Director Curis Inc Feb. 19, 2013 - June 2, 2014
President, Chief Executive Officer, Director Curis Inc Sept. 1, 2001 - Feb. 19, 2013

Dan Passeri's trades of Cue Biopharma Inc's stock


Loading...
Purchase Sale Planned purchase Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value
Number of shares Price Value Details
2024-12-18 2024-12-16 B Purchase
2,388 +5.6%
191.40
US$1,740,582
2,388 +5.6% 191.40 US$1,740,582
2023-08-16 2023-08-14 B Purchase
74,597 +14.4%
149.26
US$2,116,406
74,597 +14.4% 149.26 US$2,116,406
2021-09-27 2021-09-24 B Purchase
25,697 -18.4%
341.35
US$2,805,638
25,697 -18.4% 341.35 US$2,805,638
2019-06-25 2019-06-21 B Purchase
1,377 +2.7%
7.26
US$9,997
1,377 +2.7% 7.26 US$9,997
2019-06-07 2019-06-06 B Purchase
3,000 +6.3%
6.90
US$20,700
3,000 +6.3% 6.90 US$20,700